Tag: VT ablation
European registry elucidates safety outcomes of ventricular arrhythmia treatment with Affera...
A novel cardiac ablation system may hold the potential to improve upon the currently available treatments for ventricular arrhythmia (VA) patients, having demonstrated positive...
Medtronic announces first patient enrolment in trial assessing VT treatment with...
Medtronic recently announced that the first patient has been enrolled in a US Food and Drug Administration (FDA) early feasibility study evaluating the Affera...
FieldForce ablation system earns US FDA TAP pilot acceptance and breakthrough...
Field Medical has announced that its FieldForce ablation system has been accepted into the US Food and Drug Administration (FDA)’s Total Product Life Cycle Advisory...
AHA 2024: Ablation potentially superior to medication for post-heart attack VT
Ablation may be a better first-line treatment for heart attack survivors experiencing dangerous episodes of ventricular tachycardia (VT), according to late-breaking science presented recently...
Adagio completes first procedures in pivotal study of VT cryoablation system
Adagio Medical has announced the completion of the first procedures in the FULCRUM-VT US Food and Drug Administration (FDA) pivotal investigational device exemption (IDE)...
Rate of early death after ventricular tachycardia ablation as high as...
Early post-procedural mortality occurred in 5% of cases of radiofrequency catheter ablation in patients with scar-related ventricular tachycardia (VT), with more than half of...
Multielectrode mapping may be more effective than point-by-point mapping for VT...
Results from the first randomised study comparing multielectrode mapping vs. conventional point-by-point mapping for ventricular tachycardia (VT) substrate ablation procedures have shown that a...